Similar articles for PMID: 15004178

Year	Number of Results
1992	1
1994	3
1995	4
1997	2
1998	1
1999	2
2000	5
2001	4
2002	10
2003	4
2004	8
2005	10
2006	6
2007	2
2008	4
2009	2
2010	2
2011	4
2012	6
2013	4
2015	4
2016	3
2017	3
2018	2
2019	1
2021	1
2022	1
2024	0

1

Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.

Biswas PS, Banerjee K, Kim B, Rouse BT. Biswas PS, et al. J Immunol. 2004 Mar 15;172(6):3736-44. doi: 10.4049/jimmunol.172.6.3736. J Immunol. 2004. PMID: 15004178

2

Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein.

Biswas PS, Banerjee K, Zheng M, Rouse BT. Biswas PS, et al. J Leukoc Biol. 2004 Oct;76(4):868-75. doi: 10.1189/jlb.0504280. Epub 2004 Jul 16. J Leukoc Biol. 2004. PMID: 15258192

3

Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.

Rajasagi NK, Bhela S, Varanasi SK, Rouse BT. Rajasagi NK, et al. J Leukoc Biol. 2017 Nov;102(5):1159-1171. doi: 10.1189/jlb.3HI1216-511RR. Epub 2017 Jun 5. J Leukoc Biol. 2017. PMID: 28584076 Free PMC article.

4

Role of miR-155 in the pathogenesis of herpetic stromal keratitis.

Bhela S, Mulik S, Gimenez F, Reddy PB, Richardson RL, Varanasi SK, Jaggi U, Xu J, Lu PY, Rouse BT. Bhela S, et al. Am J Pathol. 2015 Apr;185(4):1073-84. doi: 10.1016/j.ajpath.2014.12.021. Epub 2015 Feb 18. Am J Pathol. 2015. PMID: 25700796 Free PMC article.

5

Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.

Kim B, Sarangi PP, Lee Y, Deshpande Kaistha S, Lee S, Rouse BT. Kim B, et al. J Leukoc Biol. 2006 Dec;80(6):1405-15. doi: 10.1189/jlb.0406295. Epub 2006 Sep 22. J Leukoc Biol. 2006. PMID: 16997857

6

Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.

Kim B, Lee S, Suvas S, Rouse BT. Kim B, et al. J Immunol. 2005 Jul 1;175(1):509-16. doi: 10.4049/jimmunol.175.1.509. J Immunol. 2005. PMID: 15972686

7

CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.

Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT. Banerjee K, et al. J Immunol. 2004 Jan 15;172(2):1237-45. doi: 10.4049/jimmunol.172.2.1237. J Immunol. 2004. PMID: 14707102

8

Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.

Kim B, Suvas S, Sarangi PP, Lee S, Reisfeld RA, Rouse BT. Kim B, et al. J Immunol. 2006 Sep 15;177(6):4122-31. doi: 10.4049/jimmunol.177.6.4122. J Immunol. 2006. PMID: 16951377

9

Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis.

Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT. Biswas PS, et al. J Virol. 2005 Aug;79(16):10589-600. doi: 10.1128/JVI.79.16.10589-10600.2005. J Virol. 2005. PMID: 16051851 Free PMC article.

10

Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.

Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Zheng M, et al. J Virol. 2001 Oct;75(20):9828-35. doi: 10.1128/JVI.75.20.9828-9835.2001. J Virol. 2001. PMID: 11559816 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year